Related Experiment Video
Updated: Jul 8, 2026
08:31
Optimized Griess Reaction for UV-Vis and Naked-eye Determination of Anti-malarial Primaquine
Published on: October 11, 2019
2-Oxotetrahydroquinoline-based antimalarials with high potency and metabolic stability
Vivek J Bulbule1, Kasey Rivas, Christophe L M J Verlinde
1Departments of Chemistry, Medicine, and Biochemistry, University of Washington, Seattle, Washington 98195. gelb@chem.washington.edu.
Journal of Medicinal Chemistry
|January 18, 2008
Summary
Novel 2-oxotetrahydroquinoline compounds selectively inhibit malaria parasite protein farnesyltransferase. These potent inhibitors show enhanced metabolic stability, offering a promising new avenue for malaria treatment.
Area of Science:
- Medicinal Chemistry
- Parasitology
- Drug Discovery
Background:
- Protein farnesyltransferase (PFT) is a validated target for anti-malarial drug development.
- Existing PFT inhibitors often lack selectivity or sufficient metabolic stability.
Purpose of the Study:
- To synthesize and characterize novel 2-oxotetrahydroquinoline-based inhibitors of protein farnesyltransferase.
- To evaluate the anti-malarial activity and metabolic stability of these novel compounds.
Main Methods:
- Efficient synthesis of 2-oxotetrahydroquinoline derivatives.
- In vitro enzymatic assays to determine PFT inhibition.
- Plasmodium falciparum growth inhibition assays.
- Metabolic stability assessments.
Main Results:
- A series of novel 2-oxotetrahydroquinoline inhibitors were successfully synthesized.
- Compounds demonstrated selective inhibition of malaria PFT over human PFT.
- Potent inhibition of malaria parasite growth was observed in the low nanomolar range.
- Several compounds exhibited significantly improved metabolic stability compared to related structures.
Conclusions:
- The 2-oxotetrahydroquinoline scaffold represents a promising platform for developing novel anti-malarial agents.
- The synthesized compounds display desirable potency, selectivity, and metabolic stability profiles.
- Further investigation of these inhibitors is warranted for potential therapeutic applications against malaria.
Related Concept Videos
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
01:17Oxidation of Phenols to Quinones
In the presence of oxidizing agents, phenols are oxidized to quinones. Quinones can be easily reduced back to phenols using mild reducing agents. The electron-donating hydroxyl group enhances the reactivity of the aromatic ring, enabling oxidation of the ring even in the absence of an α hydrogen.
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox property is crucial in...
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox property is crucial in...
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
01:30The Electron Transport Chain
The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q in...
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q in...
01:24Cholinergic Antagonists: Pharmacokinetics
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and the conjunctiva.